Monoclonal Gammopathy of Undetermined Significance

Monoclonal Gammopathy of Undetermined Significance — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04850846	Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma	active not recruiting	Phase 2	60	Dana-Farber Cancer InstituteOTHER	1	Feb 9, 2026	clinicaltrials
NCT05065554	ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy	active not recruiting	Phase 2	12	Shayna Sarosiek, MDOTHER	1	Dec 5, 2025	clinicaltrials